Safety and Tolerability of Long-Term Administration of Hydromorphone HCI CR (Controlled Release)
NCT00410748
·
clinicaltrials.gov ↗
PHASE3
Phase
COMPLETED
Status
388
Enrollment
INDUSTRY
Sponsor class
Conditions
Pain
Analgesics, Opioid
Interventions
DRUG:
OROS hydromorphone HCI CR
Sponsor
Alza Corporation, DE, USA